Abstract:
Methods of treating autoimmune disorders, coronary artery disease, allergy symptoms, allograft rejection sepsis/toxic shock are disclosed. Some methods comprise administering one or more regulatory compositions to activate the T suppressor cells by increasing the acetylation level and/or protein level of FOXP3 in combination with a T suppressor stimulus and/or an antigen. Some methods comprise administering one or more regulatory compositions to activate the T suppressor cells by increasing the acetylation level and/or protein level of FOXP3. Some methods comprise administering soluble GITR or antibodies that bind to GITR ligand. Methods of treating cancer, infectious diseases, and immune deficiency are also disclosed as are vaccination methods. The methods comprise administering one or more regulatory compositions to inactivate the T suppressor cells by reducing the acetylation level and/or protein level of FOXP3. Improved vaccines and vaccination methods are disclosed. Methods of identifying compounds that are useful to modulate acetylation level and/or protein level of FOXP3 and treat diseases are disclosed.
Abstract:
The present invention provides dithiolopyrrolone compounds of the general formula I, and their salts, wherein A is sulfur or carbon, and R1, R2, and R3 are selected from groups defined herein, and wherein when A is sulfur, then B is oxygen, and n=1 or 2, and when A is carbon, then B is oxygen or sulfur, and n=1. The compounds are useful for the prevention and treatment of microbial infections such as HIV infection, and for the treatment of blood disorders, such as neutropenia. In particular, the compounds are useful for the manufacture of medicaments for increasing white blood cells.
Abstract translation:本发明提供通式I的二硫代环吡咯酮化合物及其盐,其中A为硫或碳,R1,R2和R3选自本文定义的基团,其中当A为硫时,B为氧, n = 1或2,当A为碳时,B为氧或硫,n = 1。 这些化合物可用于预防和治疗诸如HIV感染的微生物感染,以及用于治疗血液病症,例如中性白细胞减少症。 特别地,这些化合物可用于制备用于增加白细胞的药物。
Abstract:
The present invention relates to a system for implementing resource allocation in network communication and a method thereof. It effectively solves the end-to-end QOS problem through dividing a communication network into a plurality of QOS domains and managing them. In the present invention, only end-to-end path information is maintained at the QER of the QOS domain that is directly connected with the source/destination terminal, while only edge-to-edge resource reservation information for aggregate flows is maintained at other QERs, thus significantly reducing flow state information maintained at the network nodes as well as overhead of signaling protocol processing and storage at the network nodes.
Abstract:
An improved receiver and method estimate one or more parameters, such as amplitude and signal-to-noise ratio, of a received signal, such as an M-QAM or q-ASK signal. The amplitude of an M-QAM signal is estimated based upon known or ascertainable phase information regarding a plurality of transmitted symbols. The amplitude of a q-ASK signal is estimated based upon known or ascertainable magnitude information regarding a plurality of transmitted symbols. In another embodiment, the amplitude of an M-QAM or q-ASK signal is estimated based on statistical knowledge of the amplitude of the transmitted symbols. Other embodiments estimate amplitude, noise power, and signal-to-noise ratio of a received signal utilizing second-order and fourth-order moments of received samples, a maximum likelihood searching process, or a Kurtosis estimation process.
Abstract:
The invention is drawn to novel macrolide compounds of formula I having antibiotic and antineoplastic activities, useful as medicaments and/or agrochemicals for microorganism infections, in particularly for infectious diseases involving drug-resistant Staphylococcus, and for treatment of human and animal cancers.
Abstract:
A receiver or an integrated circuit (IC) incorporated therein includes a fast Fourier transform (FFT)-based (or hybrid FFT-based) sliding window block level equalizer (BLE) for generating equalized samples. The BLE includes a noise power estimator, first and second channel estimators, an FFT-based chip level equalizer (CLEQ) and a channel monitor unit. The noise power estimator generates a noise power estimate based on two diverse sample data streams. The channel estimators generate respective channel estimates based on the sample data streams. The channel monitor unit generates a first channel monitor signal including truncated channel estimate vectors based on the channel estimates, and a second channel monitor signal which indicates an approximate rate of change of the truncated channel estimate vectors. The FFT-based CLEQ generates the equalized samples based on the noise power estimate, one-block samples of the first and second sample data streams, the channel estimates and the monitor signals.
Abstract:
Methods, systems and kits are provided for detecting molecules expressing a selected epitope in a sample through use of an epitope detector containing a single chain Fv for the selected epitope or a constrained epitope specific CDR, CDR mimetic or engineered CDR structure attached to an oligonucleotide.
Abstract:
An improved system and method for estimating one or more parameters, such as amplitude and signal-to-noise ratio, of a received signal, such as an M-QAM or q-ASK signal, is set forth herein. The amplitude of an M-QAM signal is estimated based upon known or ascertainable phase information regarding a plurality of transmitted symbols. The amplitude of a q-ASK signal is estimated based upon known or ascertainable magnitude information regarding a plurality of transmitted symbols. In another embodiment, the amplitude of an M-QAM or q-ASK signal is estimated based on statistical knowledge of the amplitude of the transmitted symbols. Other embodiments of the present invention estimate amplitude, noise power, and signal-to-noise ratio of a received signal utilizing second-order and fourth-order moments of received samples, a maximum likelihood searching process, or a Kurtosis estimation process.